Nia Therapeutics

📍 Boston, United States🗓 Founded 2018👥 19 employees💰 Last funded Oct 2025
Nia Therapeutics is developing a precision neurostimulation therapy for the treatment of memory loss. More than 27M Americans are living with memory loss due to traumatic brain injury, degenerative disease and aging, and there are currently no effective therapies available. Our core technology was developed with funding from the Dept. of Defense, and it utilizes artificial intelligence to personalize each patients therapy based upon their unique patterns of brain activity. Our therapeutic strategy has been validated in multiple clinical publications, and we have demonstrated the functionality of our commercial prototype in a large animal model. Our first clinical target is memory loss due to traumatic brain injury, a large market that will provide a launchpad into the larger mild cognitive impairment and Alzheimers markets.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Czech Republic
1
Frequently asked questions
Who invested in Nia Therapeutics?
Nia Therapeutics has 1 investors on record on gritt.io and 1 late-stage investors.
When did Nia Therapeutics last raise funding?
The most recent investment in Nia Therapeutics recorded on gritt.io was in October 2025.
When was Nia Therapeutics founded?
Nia Therapeutics was founded in 2018.
What industry is Nia Therapeutics in?
Nia Therapeutics operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Nia Therapeutics based?
Nia Therapeutics is headquartered in Boston, United States.